{"id":62801,"date":"2026-03-17T16:06:38","date_gmt":"2026-03-17T15:06:38","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/ris-rx-introduces-new-brand-as-gtn-revenue-protection-gains-momentum-across-pharmaceutical-industry\/"},"modified":"2026-03-17T16:06:38","modified_gmt":"2026-03-17T15:06:38","slug":"ris-rx-introduces-new-brand-as-gtn-revenue-protection-gains-momentum-across-pharmaceutical-industry","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/ris-rx-introduces-new-brand-as-gtn-revenue-protection-gains-momentum-across-pharmaceutical-industry\/","title":{"rendered":"RIS Rx Introduces New Brand as GTN Revenue Protection Gains Momentum Across Pharmaceutical Industry"},"content":{"rendered":"
\n

\nBrand refresh reflects growing industry focus on protecting patient affordability investments and improving visibility across the Gross-to-Net ecosystem<\/i><\/p>\n

<\/a>
<\/a><\/p>\n

IRVINE, Calif.–(BUSINESS WIRE)–#GTN<\/a>—RIS Rx<\/a> today announced a new brand identity and messaging platform reflecting its expanding role in addressing one of the pharmaceutical industry\u2019s most persistent financial and operational challenges: Gross-to-Net (GTN) revenue leakage<\/b>.<\/p>\n

\nThe refreshed brand centers on a discipline RIS Rx helped pioneer\u2014real-time<\/b> GTN Revenue Protection<\/b>\u2014which focuses on identifying and preventing GTN revenue leakage before<\/i> it occurs.<\/p>\n

\nFor pharmaceutical manufacturers, the Gross-to-Net spread represents one of the largest and least transparent components of the income statement. PBM policies such as maximizers and accumulators, payer policies, pharmacy transactions, and patient eligibility rules can create blind spots that allow billions<\/i> of dollars<\/b> intended for patient affordability to be diverted or misapplied.<\/p>\n

\nRIS Rx\u2019s platform integrates into existing affordability and patient support ecosystems to provide real-time intervention, monitoring and analytics\u2014before<\/i> a patient\u2019s first prescription fill<\/b>. Through real-time patient segmentation and program verification, the company helps manufacturers ensure that affordability dollars are directed to the appropriate patients and programs at the moment they are needed.<\/p>\n

\n\u201cPharmaceutical manufacturers are increasingly realizing that GTN is not just an accounting exercise\u2014it\u2019s an operational challenge that directly impacts patient access and brand performance,\u201d said Gerard Rivera, CEO and Co-founder of RIS Rx<\/b><\/a>. \u201cOur mission is to bring integrity, visibility, and accountability to that process so manufacturers can ensure the support they allocate for patients actually reaches those patients.\u201d<\/p>\n

\nFounded by pharmacists, RIS Rx combines clinical expertise with advanced analytics to identify, prevent, and quantify GTN leakage across affordability programs. The company\u2019s solutions bolt on seamlessly with existing copay vendors and hub providers, enabling rapid deployment with no disruption to patients or established workflows.<\/p>\n

\nTo date, RIS Rx has helped pharmaceutical manufacturers generate more than $1 billion in annual savings across brands and programs<\/b>.<\/p>\n

\n\u201cGross-to-Net has historically been managed through retrospective analysis and periodic audits,\u201d said Stephen Hom, Co-founder, EVP and Chief Operating Officer of RIS Rx<\/b><\/a>. \u201cGTN Revenue Protection introduces a proactive model\u2014one that enables manufacturers to identify and prevent leakage in real time, before those dollars are lost.\u201d<\/p>\n

\nRIS Rx provides manufacturers with real-time visibility into affordability program performance, continuous reporting, and compliance assurance, <\/b>helping ensure that every dollar intended for patient support is used exactly as intended.<\/p>\n

\nThe company will roll out its refreshed brand across digital platforms, marketing materials, and industry engagements beginning this week.<\/p>\n

\nAbout RIS Rx<\/b><\/p>\n

\nRIS Rx is a healthcare technology company delivering real-time<\/b> gross-to-net (GTN) revenue protection<\/b> for the world\u2019s leading pharmaceutical manufacturers. Through proprietary software, real-time analytics and pharmacist-led expertise, RIS Rx helps clients optimize operations, eliminate leakage and ensure that financial assistance reaches the patients who need it most. The company has protected more than $1 billion in annual revenue for its customers. Founded in 2020 and headquartered in Irvine, California, RIS Rx serves leading pharmaceutical manufacturers across a growing portfolio of drug brands. Learn more at www.RISRx.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia Contact<\/b>
Chase Carpenter
\n
VP, Marketing
\n
chase.carpenter@risrx.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Brand refresh reflects growing industry focus on protecting patient affordability investments and improving visibility across the Gross-to-Net ecosystem IRVINE, Calif.–(BUSINESS WIRE)–#GTN—RIS Rx today announced a new brand identity and messaging platform reflecting its expanding role in addressing one of the pharmaceutical industry\u2019s most persistent financial and operational challenges: Gross-to-Net (GTN) revenue leakage. The refreshed brand … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62801","6":"format-standard","7":"category-industry"},"yoast_head":"\nRIS Rx Introduces New Brand as GTN Revenue Protection Gains Momentum Across Pharmaceutical Industry - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/ris-rx-introduces-new-brand-as-gtn-revenue-protection-gains-momentum-across-pharmaceutical-industry\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RIS Rx Introduces New Brand as GTN Revenue Protection Gains Momentum Across Pharmaceutical Industry - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Brand refresh reflects growing industry focus on protecting patient affordability investments and improving visibility across the Gross-to-Net ecosystem IRVINE, Calif.–(BUSINESS WIRE)–#GTN—RIS Rx today announced a new brand identity and messaging platform reflecting its expanding role in addressing one of the pharmaceutical industry\u2019s most persistent financial and operational challenges: Gross-to-Net (GTN) revenue leakage. The refreshed brand ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/ris-rx-introduces-new-brand-as-gtn-revenue-protection-gains-momentum-across-pharmaceutical-industry\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-17T15:06:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260317289617\/en\/2747068\/22\/RIS_Rx_logo_digital_rgb.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ris-rx-introduces-new-brand-as-gtn-revenue-protection-gains-momentum-across-pharmaceutical-industry\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ris-rx-introduces-new-brand-as-gtn-revenue-protection-gains-momentum-across-pharmaceutical-industry\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"RIS Rx Introduces New Brand as GTN Revenue Protection Gains Momentum Across Pharmaceutical Industry\",\"datePublished\":\"2026-03-17T15:06:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ris-rx-introduces-new-brand-as-gtn-revenue-protection-gains-momentum-across-pharmaceutical-industry\\\/\"},\"wordCount\":528,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ris-rx-introduces-new-brand-as-gtn-revenue-protection-gains-momentum-across-pharmaceutical-industry\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260317289617\\\/en\\\/2747068\\\/22\\\/RIS_Rx_logo_digital_rgb.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ris-rx-introduces-new-brand-as-gtn-revenue-protection-gains-momentum-across-pharmaceutical-industry\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ris-rx-introduces-new-brand-as-gtn-revenue-protection-gains-momentum-across-pharmaceutical-industry\\\/\",\"name\":\"RIS Rx Introduces New Brand as GTN Revenue Protection Gains Momentum Across Pharmaceutical Industry - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ris-rx-introduces-new-brand-as-gtn-revenue-protection-gains-momentum-across-pharmaceutical-industry\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ris-rx-introduces-new-brand-as-gtn-revenue-protection-gains-momentum-across-pharmaceutical-industry\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260317289617\\\/en\\\/2747068\\\/22\\\/RIS_Rx_logo_digital_rgb.jpg\",\"datePublished\":\"2026-03-17T15:06:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ris-rx-introduces-new-brand-as-gtn-revenue-protection-gains-momentum-across-pharmaceutical-industry\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ris-rx-introduces-new-brand-as-gtn-revenue-protection-gains-momentum-across-pharmaceutical-industry\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ris-rx-introduces-new-brand-as-gtn-revenue-protection-gains-momentum-across-pharmaceutical-industry\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260317289617\\\/en\\\/2747068\\\/22\\\/RIS_Rx_logo_digital_rgb.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260317289617\\\/en\\\/2747068\\\/22\\\/RIS_Rx_logo_digital_rgb.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ris-rx-introduces-new-brand-as-gtn-revenue-protection-gains-momentum-across-pharmaceutical-industry\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RIS Rx Introduces New Brand as GTN Revenue Protection Gains Momentum Across Pharmaceutical Industry\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"RIS Rx Introduces New Brand as GTN Revenue Protection Gains Momentum Across Pharmaceutical Industry - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/ris-rx-introduces-new-brand-as-gtn-revenue-protection-gains-momentum-across-pharmaceutical-industry\/","og_locale":"en_US","og_type":"article","og_title":"RIS Rx Introduces New Brand as GTN Revenue Protection Gains Momentum Across Pharmaceutical Industry - Pharma Trend","og_description":"Brand refresh reflects growing industry focus on protecting patient affordability investments and improving visibility across the Gross-to-Net ecosystem IRVINE, Calif.–(BUSINESS WIRE)–#GTN—RIS Rx today announced a new brand identity and messaging platform reflecting its expanding role in addressing one of the pharmaceutical industry\u2019s most persistent financial and operational challenges: Gross-to-Net (GTN) revenue leakage. The refreshed brand ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/ris-rx-introduces-new-brand-as-gtn-revenue-protection-gains-momentum-across-pharmaceutical-industry\/","og_site_name":"Pharma Trend","article_published_time":"2026-03-17T15:06:38+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260317289617\/en\/2747068\/22\/RIS_Rx_logo_digital_rgb.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/ris-rx-introduces-new-brand-as-gtn-revenue-protection-gains-momentum-across-pharmaceutical-industry\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/ris-rx-introduces-new-brand-as-gtn-revenue-protection-gains-momentum-across-pharmaceutical-industry\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"RIS Rx Introduces New Brand as GTN Revenue Protection Gains Momentum Across Pharmaceutical Industry","datePublished":"2026-03-17T15:06:38+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ris-rx-introduces-new-brand-as-gtn-revenue-protection-gains-momentum-across-pharmaceutical-industry\/"},"wordCount":528,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ris-rx-introduces-new-brand-as-gtn-revenue-protection-gains-momentum-across-pharmaceutical-industry\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260317289617\/en\/2747068\/22\/RIS_Rx_logo_digital_rgb.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/ris-rx-introduces-new-brand-as-gtn-revenue-protection-gains-momentum-across-pharmaceutical-industry\/","url":"https:\/\/pharma-trend.com\/en\/ris-rx-introduces-new-brand-as-gtn-revenue-protection-gains-momentum-across-pharmaceutical-industry\/","name":"RIS Rx Introduces New Brand as GTN Revenue Protection Gains Momentum Across Pharmaceutical Industry - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ris-rx-introduces-new-brand-as-gtn-revenue-protection-gains-momentum-across-pharmaceutical-industry\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ris-rx-introduces-new-brand-as-gtn-revenue-protection-gains-momentum-across-pharmaceutical-industry\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260317289617\/en\/2747068\/22\/RIS_Rx_logo_digital_rgb.jpg","datePublished":"2026-03-17T15:06:38+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/ris-rx-introduces-new-brand-as-gtn-revenue-protection-gains-momentum-across-pharmaceutical-industry\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/ris-rx-introduces-new-brand-as-gtn-revenue-protection-gains-momentum-across-pharmaceutical-industry\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/ris-rx-introduces-new-brand-as-gtn-revenue-protection-gains-momentum-across-pharmaceutical-industry\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260317289617\/en\/2747068\/22\/RIS_Rx_logo_digital_rgb.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260317289617\/en\/2747068\/22\/RIS_Rx_logo_digital_rgb.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/ris-rx-introduces-new-brand-as-gtn-revenue-protection-gains-momentum-across-pharmaceutical-industry\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"RIS Rx Introduces New Brand as GTN Revenue Protection Gains Momentum Across Pharmaceutical Industry"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62801","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62801"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62801\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62801"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62801"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62801"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}